Yahoo
NSE - Delayed Quote INR

Narayana Hrudayalaya Limited (NH.NS)

1,720.20 +5.70 (+0.33%)
At close: October 30 at 3:29:49 PM GMT+5:30
NH.NS Q2 2027 earnings call
November 2, 2026 at 3:00 PM GMT+5:30
Chart Range Bar
Loading chart for NH.NS
  • Previous Close 1,714.50
  • Open 1,714.50
  • Bid --
  • Ask 1,720.20 x --
  • Day's Range 1,705.20 - 1,734.80
  • 52 Week Range 1,589.00 - 2,093.30
  • Volume 112,507
  • Avg. Volume 252,581
  • Market Cap (intraday) 349.372B
  • Beta (5Y Monthly) 0.12
  • PE Ratio (TTM) 40.44
  • EPS (TTM) 42.54
  • Earnings Date --
  • Forward Dividend & Yield 4.50 (0.26%)
  • Ex-Dividend Date Jul 17, 2026
  • 1y Target Est 2,238.42

Narayana Hrudayalaya Limited provides medical and healthcare services in India, the United Kingdom, and the Cayman Islands. It operates through the Medical and Healthcare Related Services; and Others segments. The company offers oncology, anesthesiology, audiology, blood bank, breast oncology, oncoplastic surgery, cardiac surgery, cardiology, clinical genetics, clinical immunology, clinical nutrition and dietetics, clinical psychology, congenital adult heart disease, cosmetology, cranio-maxillofacial surgery, critical care medicine, dental, dermatology, diabetology, ENT, emergency medicine, endocrinology, family medicine, general and GI surgery, general medicine and surgery, geriatric medicine, gynecology, hematology, headache and facial pain management, transplant, infectious diseases, neurology, radiology, hepatobiliary surgery, gastroenterology, minimal access GI and bariatric surgery, neonatology, nephrology, neuro-otology, neuro-rehabilitation, neurosurgery and spine surgery, and nuclear medicine services. It also provides ophthalmology, orthopedics and joint replacement, pain management and palliative care, pathology, perinatology and fetal intervention, physical medicine and rehabilitation, physiotherapy and physical rehabilitation, plastic surgery, psychiatry, pulmonology, reproductive medicine, rheumatology, renal science, speech and swallow rehabilitation, spine surgery, thoracic and vascular surgery, uro oncology, urology, and other services. In addition, the company acquires, owns, and operates hospitals, clinics, health centers, diagnostic centers, and nursing homes. Further, it provides health insurance, consultancy services in the field of healthcare and hospitals, and IT services related to healthcare. Additionally, the company engages in investment activities; and develops software related to the healthcare industry. The company was incorporated in 2000 and is headquartered in Bengaluru, India.

www.narayanahealth.org

11,234

Full Time Employees

March 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

NH.NS
8.88%
S&P BSE SENSEX (^BSESN)
12.63%

1-Year Return

NH.NS
3.95%
S&P BSE SENSEX (^BSESN)
11.78%

3-Year Return

NH.NS
71.25%
S&P BSE SENSEX (^BSESN)
16.14%

5-Year Return

NH.NS
233.81%
S&P BSE SENSEX (^BSESN)
25.55%

Earnings Trends

View More

Earnings Per Share

GAAP
Normalized
GAAP
Normalized

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY27
Revenue 28.44B
Earnings 3.01B
Profit Margin 10.58%

Q3

FY26

Q4

FY26

Q1

FY27

Q2

FY27

0
10B
20B
6.0%
7.0%
8.0%
9.0%
10.0%

Analyst Insights

View More

Analyst Price Targets

1,835.00
2,238.42 Average
1,720.20 Current
2,559.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    9.00%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    90.72B

  • Net Income Avi to Common (ttm)

    8.21B

  • Diluted EPS (ttm)

    42.54

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    25.2B

  • Total Debt/Equity (mrq)

    129.03%

  • Levered Free Cash Flow (ttm)

    --

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: